Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Patrick Purdon
Massachusetts General Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Pascall Systems, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Purdon is a co-founder of Pascall Systems, Inc. and has equity in the private company. The company is developing closed-loop physiological control technologies for anesthesia, which involve EEG monitoring. The research project seeks to characterize the EEG signatures of fentanyl in patients, in the highly controlled confines of the operating room, where fentanyl is routinely administered for general anesthesia. The goal is to understand the relationships between EEG oscillations and the state of fentanyl-induced unconsciousness, to help develop new monitors to improve care of opioid overdose patients. If the research is successful and a well-defined EEG signature of fentanyl were identified, it is possible that this information could be used to inform closed-loop physiological control of anesthesia. Therefore, the results of this research could be of interest to the company. The Partners Committee on Outside Activities review panel evaluated the financial interest in connection with this research project and determined that, based on the close connection between the company’s interests and the research, the financial interest could directly and significantly affect the design, conduct, or reporting of the research.
A pilot study to characterize brain dynamic biomarkers of fentanyl for opioid overdose monitoring
In this project, we propose to characterize the EEG signatures of fentanyl in patients, in the highly controlled confines of the operating room, where fentanyl is routinely administered for general anesthesia. Our goal is to understand the relationships between EEG oscillations and the state of fentanyl-induced unconsciousness, to help develop new monitors to improve care of opioid overdose patients.
Filed on April 01, 2019.
Tell us what you know about Patrick Purdon's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Patrick Purdon filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Patrick Purdon | Massachusetts General Hospital | Conflict of Interest | Pascall Systems, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.